The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer

Copy For Citation

Carson R., ÇELTİKÇİ B., Johnston P. G., Van Schaeybroeck S., Dunne P.

MOLECULAR CANCER THERAPEUTICS, 10 - 13 November 2013, vol.12

• Publication Type: Conference Paper
• Volume: 12
• Doi Number: 10.1158/1535-7163.targ-13-b64
• Hacettepe University Affiliated: Yes